OpenClinica
is launching a program designed to match OpenClinica’s Enterprise technology with Contract Research Organization (CRO) services to deliver enhanced customer offerings.
Ben Baumann, OpenClinica’s director of business development, says this program will be appropriate for both domestic and international organizations.
“As the leader in using open source technology to improve clinical research, OpenClinica, is expanding its capabilities and reach by partnering with other forward thinking organizations who understand the substantial value that a professionally implemented and well developed open source solution can bring to clinical trial operations,” Baumann said.
OpenClinica is expanding the OpenClinica Partner Program to:
OpenClinica is presently fielding inquiries from companies interested in learning more about the Partner Program. For more information go to:
https://www.openclinica.com/partner-inquiry
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Gilead Shares Final Data from Phase III MYR301 Trial of Bulevirtide in Chronic Hepatitis Delta Virus
May 7th 2025Long-term results from the study show 90% of patients with chronic HDV who achieved undetectable HDV RNA at 96 weeks of treatment remained undetectable for nearly 2 years post-treatment.